BPC-157 + TB-500 in rat Achilles tendon healing — direct combination study
Joint Diseases and Related Surgery / PubMed
TL;DR
Promising in rats, especially for TB-500: both peptides improved signs of Achilles tendon healing, but the popular BPC-157 + TB-500 combination did not outperform the individual treatments.
Preclinical · randomized rat Achilles-tendon repair study · 32 rats
What was studied
The question.
The researchers wanted to know whether BPC-157, TB-500, or the two combined would improve healing after a surgically cut and repaired Achilles tendon, and whether combining the peptides would work better than either one alone.
How it was conducted
The study design.
Thirty-two male Sprague-Dawley rats underwent standardized Achilles tendon transection and repair, then were randomized into four groups of eight: control, BPC-157, TB-500, or BPC-157 + TB-500. Treatment was given intraperitoneally for four weeks. Researchers then tested how much force the repaired tendon could withstand and examined tendon structure, collagen organization and degeneration under the microscope.
What it found
Did it actually work?
- TB-500 produced a statistically significant increase in maximum load to failure versus control, meaning the repaired tendons were mechanically stronger at four weeks.
- TB-500 significantly improved Bonar histology scores, while both TB-500 and the combination significantly improved Movin scores, indicating better tendon architecture, collagen alignment and fewer degenerative changes.
- BPC-157 showed favorable numerical changes, but its total histology scores did not reach statistical significance.
- The BPC-157 + TB-500 combination did not provide additional benefit over either peptide alone. The study did not demonstrate a synergistic 'Wolverine stack' effect.
Why it matters
How to read this result.
This is unusually relevant preclinical evidence because it directly tested BPC-157 and TB-500 separately and together in the same tendon-healing model. The results support a potentially positive effect on tendon repair, particularly for TB-500, while challenging the assumption that stacking the two necessarily works better.
Keep in mind
What the study does not prove.
- This was a rat study, so it does not prove the same tendon-healing benefit occurs in humans.
- There were only eight animals per treatment group and the experiment ended at four weeks.
- The study tested specific intraperitoneal doses after surgical tendon injury; it does not validate online dosing protocols, product quality or use for other injuries.
Original source
Want to read the original?
We summarize the study here first. The original source is there when you want the full methods, statistics, tables and author discussion.
Read the free full paper